A 48-year-old man undergoing orthotopic heart transplantation for ischemic cardiomyopathy developed severe right heart failure. Severe intractable bleeding complicated implantation of a right ventricular assist device. Treatment with 9.6 mg of recombinant activated factor VII stopped the bleeding, and the patient could be transferred to the intensive care unit. This is the first reported case of the successful use of recombinant activated factor VII to control bleeding with subsequent right ventricular assist device function.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.healun.2003.12.001 | DOI Listing |
Publication Analysis
Top Keywords
factor vii
12
ventricular assist
12
assist device
12
vii control
8
control bleeding
8
bleeding patient
8
heart transplantation
8
recombinant activated
8
activated factor
8
recombinant factor
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!